Effects of the Sodium‐Glucose Cotransporter‐2 Inhibitor Velagliflozin on Insulin Concentrations in Horses With Insulin Dysregulation

ABSTRACT Background Sodium‐glucose cotransporter‐2 inhibitors (SGLT2i) are promising treatments to manage hyperinsulinemia in horses with insulin dysregulation (ID). Hypothesis The SGLT2i velagliflozin decreases insulin concentration in horses with ID. Animals Privately‐owned adult horses (n = 37) w...

Cijeli opis

Bibliografski detalji

Glavni autori:	Kristen Thane, Rebecca Voth, Rebecca Klee, Tobias Warnken, Victor Chukwu, Nicholas Frank
Format:	Artigo
Jezik:	Inglês
Izdano:	Oxford University Press 2025-11-01
Serija:	Journal of Veterinary Internal Medicine
Teme:	endocrinology equine metabolic syndrome insulin dysregulation laminitis oral sugar test
Online pristup:	https://doi.org/10.1111/jvim.70256
Oznake:	Dodaj oznaku Bez oznaka, Budi prvi tko označuje ovaj zapis!